Invention Grant
US08324265B2 Heterocyclic compounds having type I 11β hydroxysteroid dehydrogenase inhibitory activity
有权
具有I 11和bgr的杂环化合物 羟类固醇脱氢酶抑制活性
- Patent Title: Heterocyclic compounds having type I 11β hydroxysteroid dehydrogenase inhibitory activity
- Patent Title (中): 具有I 11和bgr的杂环化合物 羟类固醇脱氢酶抑制活性
-
Application No.: US12093903Application Date: 2006-11-20
-
Publication No.: US08324265B2Publication Date: 2012-12-04
- Inventor: Noriyuki Kurose , Mikayo Hayashi , Tomoyuki Ogawa , Koji Masuda , Eiichi Kojima
- Applicant: Noriyuki Kurose , Mikayo Hayashi , Tomoyuki Ogawa , Koji Masuda , Eiichi Kojima
- Applicant Address: JP Osaka
- Assignee: Shionogi & Co., Ltd.
- Current Assignee: Shionogi & Co., Ltd.
- Current Assignee Address: JP Osaka
- Agency: Hamre, Schumann, Mueller & Larson, P.C.
- Priority: JP2005-335995 20051121
- International Application: PCT/JP2006/323096 WO 20061120
- International Announcement: WO2007/058346 WO 20070524
- Main IPC: A61K31/551
- IPC: A61K31/551 ; A61K31/5377 ; A61K31/506 ; A61K31/496 ; A61K31/454 ; A61K31/4439 ; A61K31/427 ; A61K31/4245 ; A61K31/4178 ; A61K31/4155 ; A61K31/415 ; C07D417/06 ; C07D417/12 ; C07D413/06 ; C07D413/12 ; C07D409/06 ; C07D409/12 ; C07D401/14 ; C07D401/12 ; C07D401/06 ; C07D403/06 ; C07D403/12 ; C07D231/20 ; C07D231/18

Abstract:
Disclosed is a compound useful as a type I 11βhydroxysteroid dehydrogenase inhibitor.A compound represented by the formula: a pharmaceutically acceptable salt or solvate thereof, wherein R1 is optionally substituted alkyl or the like, one of R2 and R4 is a group of formula: —Y—R5, wherein Y is —O— or the like, R5 is substituted alkyl (the substituent is optionally substituted cycloalkyl or the like), optionally substituted branched alkyl or the like, the other of R2 and R4 is hydrogen or optionally substituted alkyl, R3 is a group of formula: —C(═O)—Z—R6, wherein Z is —NR7— or —NR7—W—, R6 is optionally substituted cycloalkyl or the like, R7 is hydrogen or optionally substituted alkyl, W is optionally substituted alkylene, X is ═N— or the like, with the proviso that compounds wherein R2 is 2-(morphorino)ethoxy, R3 is N-(1-adamantyl)carbamoyl and R1 is benzyl are excluded.
Public/Granted literature
- US20090170832A1 HETEROCYCLIC COMPOUNDS HAVING TYPE I 11beta HYDROXYSTEROID DEHYDROGENASE INHIBITORY ACTIVITY Public/Granted day:2009-07-02
Information query